This CTD dossier owner and manufacturer, established over three decades ago in South Asia, has become a prominent player in the global pharmaceutical market. Their focus lies in manufacturing and exporting a wide array of pharmaceutical products, including prescription and over-the-counter medications, to regulated and non-regulated markets worldwide. They have a strong presence in regions like Latin America, the Middle East, CIS, and Asia, with a subsidiary established in the Caucasus. Their commitment to quality is evident through adherence to WHO GMP standards, along with EU and USFDA guidelines. They specialize in manufacturing solid dosage forms and have a diverse range of therapeutic areas, although specific details were not provided.

This globally operating pharmaceutical company focuses on developing and manufacturing a broad range of affordable medications. They specialize in both prescription and over-the-counter drugs, including oncology treatments, antibacterials, injectables (both specialty and large volume), ophthalmic products, dermatological preparations, and veterinary pharmaceuticals. Their product portfolio also includes unique niche drugs and orphan products, showcasing their commitment to addressing diverse medical needs. The company boasts state-of-the-art manufacturing facilities located across several regions, adhering to strict quality standards recognized by international regulatory bodies like the WHO GMP, US FDA, and MCC. Their extensive global reach spans over 45 countries in Asia, Africa, Latin America, CIS, Europe, Australia, and the Pacific Ocean. The company's focus on research and development, coupled with its global manufacturing capabilities and commitment to quality, positions them as a key player in the international pharmaceutical market.